Baron Funds, an investment management company, released its “Baron Opportunity Fund” third-quarter 2025 investor letter. A ...

Bristlemoon Capital, a global equities firm, released its “Bristlemoon Global Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund returned 5.0% in the ...

Fintel reports that on September 10, 2025, Rosenblatt downgraded their outlook for Synopsys (NasdaqGS:SNPS) from Buy to Neutral. Analyst Price Forecast Suggests 8.15% Upside As of September 2, 2025, ...

Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The equity market continued ...

Synopsys (SNPS) stock is down 35.8% in a day. The sell-off comes as the semiconductor design software vendor posted quarterly results that missed analysts’ expectations, while also lowering its ...

Wall Street analysts expect Synopsys (SNPS) to post quarterly earnings of $3.84 per share in its upcoming report, which indicates a year-over-year increase of 12%. Revenues are expected to be $1.77 ...

The investment seeks daily investment results, before fees and expenses, that correspond to two times (200%) the daily performance of the common shares of Synopsis, Inc. Under normal market ...

Below is Validea's guru fundamental report for SYNOPSYS INC (SNPS). Of the 22 guru strategies we follow, SNPS rates highest using our Growth Investor model based on the published strategy of Martin ...

Provider-led I-SNPs have driven down resident hospitalizations, but their effect on other key clinical measures is questionable, a new study shows.